These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 9166513
1. Primary central nervous system lymphoma: curable without toxicity? DeAngelis LM. Cancer J Sci Am; 1996; 2(3):137-9. PubMed ID: 9166513 [No Abstract] [Full Text] [Related]
2. Advances for the treatment of primary central nervous system lymphoma (review). Yamanaka R, Tanaka R. Oncol Rep; 2004 Sep; 12(3):563-8. PubMed ID: 15289838 [Abstract] [Full Text] [Related]
4. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J. Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169 [Abstract] [Full Text] [Related]
6. Questions and answers in the management of primary central nervous system and ocular lymphomas. Ferreri AJ, Dell'oro S, Reni M, Foppoli M, Anzalone N, Govi S, Picozzi P, Truci G, Ponzoni M. Haematologica; 2003 Sep 01; 88(9):1063-8. PubMed ID: 12969815 [No Abstract] [Full Text] [Related]
7. Combining etoposide and dexrazoxane synergizes with radiotherapy and improves survival in mice with central nervous system tumors. Hofland KF, Thougaard AV, Dejligbjerg M, Jensen LH, Kristjansen PE, Rengtved P, Sehested M, Jensen PB. Clin Cancer Res; 2005 Sep 15; 11(18):6722-9. PubMed ID: 16166453 [Abstract] [Full Text] [Related]
8. [Primary central nervous system lymphoma: a report of 28 patients]. Hu Y, Feng FY, Shi YK, Zhou LQ, Gu DZ, Wang QL. Zhonghua Zhong Liu Za Zhi; 2004 Jun 15; 26(6):375-8. PubMed ID: 15312352 [Abstract] [Full Text] [Related]
9. MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas. Ferreri AJ, Dell'Oro S, Foppoli M, Bernardi M, Brandes AA, Tosoni A, Montanari M, Balzarotti M, Spina M, Ilariucci F, Zaja F, Stelitano C, Bobbio F, Corazzelli G, Baldini L, Ponzoni M, Picozzi P, Caligaris Cappio F, Reni M. Neurology; 2006 May 09; 66(9):1435-8. PubMed ID: 16682682 [Abstract] [Full Text] [Related]
11. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. Poortmans PM, Kluin-Nelemans HC, Haaxma-Reiche H, Van't Veer M, Hansen M, Soubeyran P, Taphoorn M, Thomas J, Van den Bent M, Fickers M, Van Imhoff G, Rozewicz C, Teodorovic I, van Glabbeke M, European Organization for Research and Treatment of Cancer Lymphoma Group. J Clin Oncol; 2003 Dec 15; 21(24):4483-8. PubMed ID: 14597741 [Abstract] [Full Text] [Related]
15. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system. Illerhaus G, Müller F, Feuerhake F, Schäfer AO, Ostertag C, Finke J. Haematologica; 2008 Jan 15; 93(1):147-8. PubMed ID: 18166803 [Abstract] [Full Text] [Related]
17. Primary central nervous system lymphoma with testicular metastasis. Liu XJ, Zhao JZ, Li G, Ye X, Yan PX. Clin Neurol Neurosurg; 2012 Jan 15; 114(1):80-3. PubMed ID: 21871714 [No Abstract] [Full Text] [Related]
18. Primary CNS lymphoma: chemotherapy followed by radiotherapy or chemotherapy alone? A randomized multicentric study. Thiel E, Korfel A, Hinkelbein W. Front Radiat Ther Oncol; 1999 Jan 15; 33():349-53. PubMed ID: 10549506 [No Abstract] [Full Text] [Related]
19. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system. Jahnke K, Kraemer DF, Knight KR, Fortin D, Bell S, Doolittle ND, Muldoon LL, Neuwelt EA. Cancer; 2008 Feb 01; 112(3):581-8. PubMed ID: 18072268 [Abstract] [Full Text] [Related]